Clinical Trials Logo

Stage IIB Uveal Melanoma clinical trials

View clinical trials related to Stage IIB Uveal Melanoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT02336763 Terminated - Iris Melanoma Clinical Trials

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Start date: October 2014
Phase: N/A
Study type: Interventional

This clinical trial studies giving radiation therapy to the liver in patients with uveal (eye) melanoma who have a specific chromosome loss (monosomy 3) or are DecisionDx Class 2 and therefore more likely to have their disease spread from the eye to the liver. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Early radiation to the liver may reduce the development of tumors in the liver and the overall risk of disease recurrence.